Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Nifty Pharma ETF · Direct ✕UTI Nifty Midcap 150 Exchange Traded Fund · Direct ✕

Growth of ₹10,000

Basics

Nippon India Nifty Pharma ETFUTI Nifty Midcap 150 Exchange Traded Fund
CategoryEquity ETFsEquity ETFs
PlanDirectDirect
Fund houseNippon IndiaUTI
NAV₹29.1863₹230.3012
NAV date20 Nov 202620 Nov 2026
History5.4 years3.2 years
Expense ratio0.2%0.0%
StarsNot ratedNot rated
Growth Score——

Returns

Nippon India Nifty Pharma ETFUTI Nifty Midcap 150 Exchange Traded Fund
1 month+10.82%+5.92%
3 months+7.43%−2.60%
6 months+14.54%+1.69%
YTD+25.40%+2.62%
1 year+25.57%+2.02%
3 years (CAGR)+22.02%+13.88%
5 years (CAGR)+16.60%—
10 years (CAGR)——
Since launch+14.02%+14.70%

Risk

Nippon India Nifty Pharma ETFUTI Nifty Midcap 150 Exchange Traded Fund
Volatility15.0%18.3%
Downside volatility9.0%12.5%
Sharpe1.040.40
Sortino1.720.59
Calmar1.330.66
Return / risk1.470.76
Deepest fall−20.98%−20.98%
Days to recover136262
Below its high−1.75%−3.25%

Against benchmark

Nippon India Nifty Pharma ETFUTI Nifty Midcap 150 Exchange Traded Fund
Alpha+0.00%+0.01%
Beta1.001.00
R²100.0%100.0%
Up capture100.0%100.1%
Down capture100.0%100.2%
Tracking error0.0%0.1%
Information ratio—0.19
Treynor0.140.06

Consistency

Nippon India Nifty Pharma ETFUTI Nifty Midcap 150 Exchange Traded Fund
Best 1-year+65.21%+50.21%
Middle 1-year+13.46%+7.49%
Worst 1-year−15.30%−5.89%
1-year periods with a loss25.8%12.4%
Middle 3-year+20.51%+13.87%
Positive months61.1%66.7%
Best day+3.64%+3.97%
Worst day−4.03%−7.11%
Worst 5% day−1.62%−2.00%
Positive days54.4%57.2%
NAVs a year248248

SIP of ₹10,000 a month

Nippon India Nifty Pharma ETFUTI Nifty Midcap 150 Exchange Traded Fund
5-year XIRR+20.60%—
5-year value₹10,11,738—
3-year XIRR+19.58%+7.86%
1-year XIRR+34.31%+6.12%

Holdings overlap i

Nippon India Nifty Pharma ETFUTI Nifty Midcap 150 Exchange Traded Fund
Nippon India Nifty Pharma ETF—9%
UTI Nifty Midcap 150 Exchange Traded Fund9%—

Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.

Held by all of them

StockNippon India Nifty Pharma ETFUTI Nifty Midcap 150 Exchange Traded Fund
Laurus Labs Limited9.26%2.39%
Lupin Limited4.83%1.25%
Aurobindo Pharma Limited4.59%1.19%
Glenmark Pharmaceuticals Limited3.42%0.88%
Alkem Laboratories Limited3.05%0.79%
Mankind Pharma Limited2.79%0.72%
IPCA Laboratories Limited2.65%0.69%
Biocon Limited2.42%0.63%
Ajanta Pharma Limited1.58%0.41%
Abbott India Limited1.32%0.34%

Sectors and company size

Nippon India Nifty Pharma ETFUTI Nifty Midcap 150 Exchange Traded Fund
Large companies45.3%5.8%
Mid companies47.1%90.6%
Small companies7.6%2.5%
Top 10 holdings78.6%18.3%
Largest sectorPharmaceuticals & Biotechnology 100%Pharmaceuticals & Biotechnology 10%

Search Growth